Timur Tuncali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Timur Tuncali has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Halil Gürhan Karabulut
Department of Medical Genetics, Faculty of Medicine Ankara University Ankara Turkey
4 shared publications - Şule Altıner
Department of Medical Genetics, Faculty of Medicine Ankara University Ankara Turkey
2 shared publications A. Tukun
Department of Medical Genetic, Ankara University School of Medicine
1 shared publicationA.Nurten Akarsu
1 shared publication- Ahmet Cevdet Ceylan
Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Turkey
1 shared publication Ahmet Göğüş
1 shared publication
Latest Publications
- 3 November 2026
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 65 (11)
Cytogenetic Landscape of Complex Karyotypes Across Hematological Malignancies: Common and Disease‐Specific Patterns in a Large Single‐Center Cohort
Cytogenetics remains an important method for evaluating hematological malignancies. Although recurring chromosomal abnormalities correlate with subtypes, complex karyotype (CK) has strong prognostic value related to overall survival. Cytogenetic data of patients with CK detected at the Department of Medical Genetics, Ankara University Faculty of Medicine over 8 years were examined in this study. A total of 16 437 bone marrow or peripheral blood samples were analyzed cytogenetically. Among them, 385 samples corresponding to 318 patients (2.34%) had complex cytogenetic abnormalities. Demographic characteristics, age distribution, hematological diagnoses, and cytogenetic findings were retrospectively evaluated. Among 385 CK samples, 200 (52%) were males and 29 (8%) were in the pediatric age group (defined as 18 years). The mean age at CK detection was 9.14 years (median: 9) in pediatric patients and 57.12 years (median: 60) in adults. Survival analysis showed that 33.77% of patients died within a mean of 7.55 months (median: 4) after CK detection. The consistent detection of chromosome 17p abnormalities across all groups (22% of patients) represented one of the most frequent shared cytogenetic findings in this CK cohort. Disease‐specific alterations were most common in multiple myeloma with chromosome 1 abnormalities being predominant (75%), whereas alterations of chromosomes 5 and 7 predominated in acute myeloid leukemia (61%) and myelodysplastic syndromes (50%). Cytogenetic findings suggestive of a monosomal karyotype were observed frequently in multiple myeloma (35.5%). Comparison of cytogenetic and FISH findings showed that targeted FISH panels frequently fail to detect karyotypical complexity, and diagnostic yield varies significantly among disease groups. In multiple myeloma, plasma cell‐enriched samples are more effective in detecting CK with FISH analysis compared to conventional bone marrow samples. CK remains a significant cytogenetic marker in hematological malignancies. Although genome‐wide molecular methods are increasingly available, conventional cytogenetic analysis remains more accessible in practice. This study demonstrates the value of conventional cytogenetics in CK detection and provides one of the most comprehensive datasets from Turkey.
- 3 November 2026
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 65 (11)
Cytogenetic Landscape of Complex Karyotypes Across Hematological Malignancies: Common and Disease‐Specific Patterns in a Large Single‐Center Cohort
Cytogenetics remains an important method for evaluating hematological malignancies. Although recurring chromosomal abnormalities correlate with subtypes, complex karyotype (CK) has strong prognostic value related to overall survival. Cytogenetic data of patients with CK detected at the Department of Medical Genetics, Ankara University Faculty of Medicine over 8 years were examined in this study. A total of 16 437 bone marrow or peripheral blood samples were analyzed cytogenetically. Among them, 385 samples corresponding to 318 patients (2.34%) had complex cytogenetic abnormalities. Demographic characteristics, age distribution, hematological diagnoses, and cytogenetic findings were retrospectively evaluated. Among 385 CK samples, 200 (52%) were males and 29 (8%) were in the pediatric age group (defined as 18 years). The mean age at CK detection was 9.14 years (median: 9) in pediatric patients and 57.12 years (median: 60) in adults. Survival analysis showed that 33.77% of patients died within a mean of 7.55 months (median: 4) after CK detection. The consistent detection of chromosome 17p abnormalities across all groups (22% of patients) represented one of the most frequent shared cytogenetic findings in this CK cohort. Disease‐specific alterations were most common in multiple myeloma with chromosome 1 abnormalities being predominant (75%), whereas alterations of chromosomes 5 and 7 predominated in acute myeloid leukemia (61%) and myelodysplastic syndromes (50%). Cytogenetic findings suggestive of a monosomal karyotype were observed frequently in multiple myeloma (35.5%). Comparison of cytogenetic and FISH findings showed that targeted FISH panels frequently fail to detect karyotypical complexity, and diagnostic yield varies significantly among disease groups. In multiple myeloma, plasma cell‐enriched samples are more effective in detecting CK with FISH analysis compared to conventional bone marrow samples. CK remains a significant cytogenetic marker in hematological malignancies. Although genome‐wide molecular methods are increasingly available, conventional cytogenetic analysis remains more accessible in practice. This study demonstrates the value of conventional cytogenetics in CK detection and provides one of the most comprehensive datasets from Turkey.
- 27 March 2026
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 79 (1) , 82-88
rs1800734: a risk allele for nonobstructive azoospermia related to maturation arrest
Background: Male infertility is increasingly being conceived as a biomarker of general male health status other than being a significant reproductive health issue. Nonobstructive azoospermia (NOA) patients have the worst health status impairment as well as highest risk of developing cancer. It’s well known that cancer susceptibility gene, MLH1 have roles in homologous recombination during meiosis. Mlh1 mutant mice have azoospermia with meiotic arrest. Aim: We aimed to identify risk alleles in MLH1 gene in males with nonobstructive azoospermia related maturation arrest (MA) to investigate further whether this cancer susceptibility gene is also related to male infertility. Patients and Methods: MLH1 variants were genotyped in 42 patients with MA. The variants of interest then compared to GnomAD v.3.1.2 (non-cancer) male population database and to the repository exome data of a national genetic disease evaluation center (NGDEC). Results: rs1800734 allele frequencies were significantly higher in the patient group compared to GnomAD (p
- 27 March 2026
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 79 (1) , 82-88
rs1800734: a risk allele for nonobstructive azoospermia related to maturation arrest
Background: Male infertility is increasingly being conceived as a biomarker of general male health status other than being a significant reproductive health issue. Nonobstructive azoospermia (NOA) patients have the worst health status impairment as well as highest risk of developing cancer. It’s well known that cancer susceptibility gene, MLH1 have roles in homologous recombination during meiosis. Mlh1 mutant mice have azoospermia with meiotic arrest. Aim: We aimed to identify risk alleles in MLH1 gene in males with nonobstructive azoospermia related maturation arrest (MA) to investigate further whether this cancer susceptibility gene is also related to male infertility. Patients and Methods: MLH1 variants were genotyped in 42 patients with MA. The variants of interest then compared to GnomAD v.3.1.2 (non-cancer) male population database and to the repository exome data of a national genetic disease evaluation center (NGDEC). Results: rs1800734 allele frequencies were significantly higher in the patient group compared to GnomAD (p
- 19 December 2021
- Published by Wiley in Human Mutation
- Vol. 43 (2) , 158-168
ROHMM—A flexible hidden Markov model framework to detect runs of homozygosity from genotyping data
Runs of long homozygous stretches (ROH) are considered to be the result of consanguinity and usually contain recessive deleterious disease causing mutations (Szpiech et al., 2013). Several algorithms have been developed to detect ROHs. Here, we developed a simple, alternative strategy by examining X chromosome non-pseudoautosomal region to detect the ROHs from next generation sequencing data utilizing the genotype probabilities and the Hidden Markov Model algorithm as a tool, namely ROHMM. It is implemented purely in java and contains both command-line and a graphical user interface. We tested ROHMM on simulated data as well as real population data from 1000G Project and a clinical sample. Our results have shown that ROHMM can perform robustly producing highly accurate homozygosity estimations under all conditions thereby meeting and even exceeding the performance of its natural competitors.
- 19 December 2021
- Published by Wiley in Human Mutation
- Vol. 43 (2) , 158-168
ROHMM—A flexible hidden Markov model framework to detect runs of homozygosity from genotyping data
Runs of long homozygous stretches (ROH) are considered to be the result of consanguinity and usually contain recessive deleterious disease causing mutations (Szpiech et al., 2013). Several algorithms have been developed to detect ROHs. Here, we developed a simple, alternative strategy by examining X chromosome non-pseudoautosomal region to detect the ROHs from next generation sequencing data utilizing the genotype probabilities and the Hidden Markov Model algorithm as a tool, namely ROHMM. It is implemented purely in java and contains both command-line and a graphical user interface. We tested ROHMM on simulated data as well as real population data from 1000G Project and a clinical sample. Our results have shown that ROHMM can perform robustly producing highly accurate homozygosity estimations under all conditions thereby meeting and even exceeding the performance of its natural competitors.
- 17 December 2021
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 74 (3) , 365-369
Genotype Phenotype Correlation of A Case Having Chromosome 3 Imbalance
- 17 December 2021
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 74 (3) , 365-369
Genotype Phenotype Correlation of A Case Having Chromosome 3 Imbalance
- 9 May 2020
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 52 (2) , 508-514
Coexistence of Ovarian Granulose Cell Tumor, Congenital Adrenal Hyperplasia, and Triple Translocation: Is a Consequence or Coincidence?
Purpose Congenital adrenal hyperplasia (CAH) is rare autosomal recessive disease. CAH due to 21-hydroxylase deficiency accounts for 95% of cases. We aimed to share the first case of coexistence of simple virilizing-type congenital adrenal hyperplasia [I172N mutation in the CYP21A], triple translocation [t(9;11;12)], and ovarian granulose cell tumor. Methods A 59-year-old female patient was presented to our clinic, complaining with abdominal pain and distension. Physical examination revealed palpable abdominal mass, virilism, ambiguous genitalia, clitoramegaly, and hyperpigmentation. Contrast-enhanced abdominal computed tomography showed a giant mass originating from the right tubo-ovarian structure. Results The patient was operated in the light of the clinico-radiological features mentioned above. A giant mass weighing 3500 g was detected on the right tubo-ovarian structure during laparotomy, and mass was excised with right tubo-ovarian structure. Immunohistochemical examination revealed ovarian granulosa cell tumor. The high serum concentration of 17-OH progesterone was measured at baseline and after 250-μg bolus of synthetic ACTH. In genetic analysis, we screened for six-point mutations, large deletions, and non-common mutations using restriction fragment length polymorphism (RFLP) methods, PCR, and sequencing of CYP21 gene respectively. The patient was detected to be homozygous for the I172N mutation. In addition, 50% of the metaphases examined had triple translocation [t(9;11;12)]. Conclusion The coexistence of congenital adrenal hyperplasia, triple chromosomal translocations, and ovarian granulosa cell tumor has not been described previously. This coexistence may be a sign of a new syndrome.
- 9 May 2020
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 52 (2) , 508-514
Coexistence of Ovarian Granulose Cell Tumor, Congenital Adrenal Hyperplasia, and Triple Translocation: Is a Consequence or Coincidence?
Purpose Congenital adrenal hyperplasia (CAH) is rare autosomal recessive disease. CAH due to 21-hydroxylase deficiency accounts for 95% of cases. We aimed to share the first case of coexistence of simple virilizing-type congenital adrenal hyperplasia [I172N mutation in the CYP21A], triple translocation [t(9;11;12)], and ovarian granulose cell tumor. Methods A 59-year-old female patient was presented to our clinic, complaining with abdominal pain and distension. Physical examination revealed palpable abdominal mass, virilism, ambiguous genitalia, clitoramegaly, and hyperpigmentation. Contrast-enhanced abdominal computed tomography showed a giant mass originating from the right tubo-ovarian structure. Results The patient was operated in the light of the clinico-radiological features mentioned above. A giant mass weighing 3500 g was detected on the right tubo-ovarian structure during laparotomy, and mass was excised with right tubo-ovarian structure. Immunohistochemical examination revealed ovarian granulosa cell tumor. The high serum concentration of 17-OH progesterone was measured at baseline and after 250-μg bolus of synthetic ACTH. In genetic analysis, we screened for six-point mutations, large deletions, and non-common mutations using restriction fragment length polymorphism (RFLP) methods, PCR, and sequencing of CYP21 gene respectively. The patient was detected to be homozygous for the I172N mutation. In addition, 50% of the metaphases examined had triple translocation [t(9;11;12)]. Conclusion The coexistence of congenital adrenal hyperplasia, triple chromosomal translocations, and ovarian granulosa cell tumor has not been described previously. This coexistence may be a sign of a new syndrome.
- 16 March 2018
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 154 (2) , 57-61
A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome
Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a rare multisystemic autosomal dominant disorder typically presenting with cutaneous basal cell carcinomas, multiple keratocysts, and skeletal anomalies. NBCCS is caused by heterozygous mutations in the PTCH1 gene in chromosome 9q22, in the PTCH2 gene in 1p34, or the SUFU gene in 10q24.32. Here, we report on an 18-month-old boy presenting with medulloblastoma, frontal bossing, and multiple skeletal anomalies and his father who has basal cell carcinomas, palmar pits, macrocephaly, bifid ribs, calcification of falx cerebri, and a history of surgery for odontogenic keratocyst. These clinical findings were compatible with the diagnosis of NBCCS, and a novel mutation, c.1249delC; p.Gln417Lysfs*15, was found in PTCH1 causing a premature stop codon.
- 16 March 2018
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 154 (2) , 57-61
A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome
Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a rare multisystemic autosomal dominant disorder typically presenting with cutaneous basal cell carcinomas, multiple keratocysts, and skeletal anomalies. NBCCS is caused by heterozygous mutations in the PTCH1 gene in chromosome 9q22, in the PTCH2 gene in 1p34, or the SUFU gene in 10q24.32. Here, we report on an 18-month-old boy presenting with medulloblastoma, frontal bossing, and multiple skeletal anomalies and his father who has basal cell carcinomas, palmar pits, macrocephaly, bifid ribs, calcification of falx cerebri, and a history of surgery for odontogenic keratocyst. These clinical findings were compatible with the diagnosis of NBCCS, and a novel mutation, c.1249delC; p.Gln417Lysfs*15, was found in PTCH1 causing a premature stop codon.
- Open Access
- 30 June 2016
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 31 (2) , 107-111
Lack of the Association of the PTPN22 C1858T Gene Polymorphism With Susceptibility to Familial Mediterranean Fever
Objectives: This study aims to investigate whether the protein tyrosine phosphatase non-receptor type 22 (PTPN22) C1858T gene polymorphism plays a role in the pathogenesis of familial Mediterranean fever (FMF) through T-lymphocyte activation. Patients and methods: We conducted a case-control study with 180 FMF patients (68 males, 112 females; mean age 38.2±1.6 years; range 16 to 81 years) and 184 healthy controls (86 males, 98 females; mean age 32.9±9.2 years; range 18 to 58 years). The PTPN22 C1858T polymorphism (rs2476601) was genotyped by polymerase chain reaction restriction fragment length polymorphism. In patients with FMF, clinical features, disease severity score, the frequencies of amyloidosis, positive family history, and Mediterranean fever gene mutations were determined. Results: The frequencies of heterozygous genotype (CT) were 4.5% in FMF patients and 2.8% in healthy controls, respectively. The frequencies of polymorphic homozygous genotypes (TT) were 0.5% in both FMF patients and healthy controls. There were no statistically significant differences in the frequencies of CT and TT genotypes between FMF patients and healthy controls (odds ratio: 1.65, 95% confidence interval: 0.53-5.14, p>0.05 for CT genotype). The frequencies of clinical features, sex, amyloidosis, positive family history, Mediterranean fever gene mutations, and disease severity score were not significantly different between the patients. Conclusion: The distribution of PTPN22 C1858T polymorphism did not reveal any association with FMF in a Turkish population.
- 30 June 2016
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 31 (2) , 107-111
Open AccessLack of the Association of the PTPN22 C1858T Gene Polymorphism With Susceptibility to Familial Mediterranean Fever
Objectives: This study aims to investigate whether the protein tyrosine phosphatase non-receptor type 22 (PTPN22) C1858T gene polymorphism plays a role in the pathogenesis of familial Mediterranean fever (FMF) through T-lymphocyte activation. Patients and methods: We conducted a case-control study with 180 FMF patients (68 males, 112 females; mean age 38.2±1.6 years; range 16 to 81 years) and 184 healthy controls (86 males, 98 females; mean age 32.9±9.2 years; range 18 to 58 years). The PTPN22 C1858T polymorphism (rs2476601) was genotyped by polymerase chain reaction restriction fragment length polymorphism. In patients with FMF, clinical features, disease severity score, the frequencies of amyloidosis, positive family history, and Mediterranean fever gene mutations were determined. Results: The frequencies of heterozygous genotype (CT) were 4.5% in FMF patients and 2.8% in healthy controls, respectively. The frequencies of polymorphic homozygous genotypes (TT) were 0.5% in both FMF patients and healthy controls. There were no statistically significant differences in the frequencies of CT and TT genotypes between FMF patients and healthy controls (odds ratio: 1.65, 95% confidence interval: 0.53-5.14, p>0.05 for CT genotype). The frequencies of clinical features, sex, amyloidosis, positive family history, Mediterranean fever gene mutations, and disease severity score were not significantly different between the patients. Conclusion: The distribution of PTPN22 C1858T polymorphism did not reveal any association with FMF in a Turkish population.
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 6, 470-474
Seckel syndrome with cutaneous pigmentary changes: two siblings and a review of the literature
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 6, 470-474
Seckel syndrome with cutaneous pigmentary changes: two siblings and a review of the literature
- Open Access
- 1 March 2014
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 31 (1) , 79-83
Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
Three cases of Epstein-Barr virus (EBV)-negative post-transplant lymphoproliferative disease that occurred 6 to 8 years after renal transplantation are reported. The patients respectively had gastric mucosa-associated lymphoid tissue lymphoma, gastric diffuse large B-cell lymphoma, and atypical Burkitt lymphoma. Absence of EBV in the tissue samples was demonstrated by both in situ hybridization for EBV early RNA and polymerase chain reaction for EBV DNA. Patients were treated with reduction in immunosuppression and combined chemotherapy plus an anti-CD20 monoclonal antibody, rituximab. Despite the reduction in immunosuppression, patients had stable renal functions without loss of graft functions. The patient with atypical Burkitt lymphoma had an abnormal karyotype, did not respond to treatment completely, and died due to disease progression. The other patients are still alive and in remission 5 and 3 years after diagnosis, respectively. EBV-negative post-transplant lymphoproliferative diseases are usually late-onset and are reported to have poor prognosis. Thus, reduction in immunosuppression is usually not sufficient for treatment and more aggressive approaches like rituximab with combined chemotherapy are required.\u
- 1 March 2014
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 31 (1) , 79-83
Open AccessEpstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
Three cases of Epstein-Barr virus (EBV)-negative post-transplant lymphoproliferative disease that occurred 6 to 8 years after renal transplantation are reported. The patients respectively had gastric mucosa-associated lymphoid tissue lymphoma, gastric diffuse large B-cell lymphoma, and atypical Burkitt lymphoma. Absence of EBV in the tissue samples was demonstrated by both in situ hybridization for EBV early RNA and polymerase chain reaction for EBV DNA. Patients were treated with reduction in immunosuppression and combined chemotherapy plus an anti-CD20 monoclonal antibody, rituximab. Despite the reduction in immunosuppression, patients had stable renal functions without loss of graft functions. The patient with atypical Burkitt lymphoma had an abnormal karyotype, did not respond to treatment completely, and died due to disease progression. The other patients are still alive and in remission 5 and 3 years after diagnosis, respectively. EBV-negative post-transplant lymphoproliferative diseases are usually late-onset and are reported to have poor prognosis. Thus, reduction in immunosuppression is usually not sufficient for treatment and more aggressive approaches like rituximab with combined chemotherapy are required.\u
- 27 July 2013
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 61 (2) , 147-151
Oesophageal achalasia misdiagnosed as uncontrolled asthma
Achalasia is characterized by incomplete lower oesophageal sphincter relaxation and aperistalsis of the oesophagus. It may present with dyspnea symptom. An 18-years-old male patient applied to a clinic with the complaints of cough, dyspnea, wheezing and diagnosed as asthma. Although his asthma treatment was increased in time while he did not recover, he was reffered to our hospital with the diagnosis of uncontrolled asthma. On chest X-ray there was a mild upper mediastinal enlargement and chest computed tomography revealed an over-dilated oesophagus constricting the trachea. The patient was referred to chest surgery clinic with a suspected diagnosis of achalasia. Barium-oesophagogram and endoscopic evaluation of the oesophagus confirmed the diagnosis of achalasia. The patient underwent Heller myotomy and oesophagogastrostomy. He was recovered in one week after the surgery without any complaint of dyspnea. Spirometry tests and chest X-ray resulted normal in one year. With this case of achalasia who used asthma treatment unnecessarily,we wanted to emphasize the importance of differential diagnosis of difficult asthma.
- 27 July 2013
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 61 (2) , 147-151
Oesophageal achalasia misdiagnosed as uncontrolled asthma
Achalasia is characterized by incomplete lower oesophageal sphincter relaxation and aperistalsis of the oesophagus. It may present with dyspnea symptom. An 18-years-old male patient applied to a clinic with the complaints of cough, dyspnea, wheezing and diagnosed as asthma. Although his asthma treatment was increased in time while he did not recover, he was reffered to our hospital with the diagnosis of uncontrolled asthma. On chest X-ray there was a mild upper mediastinal enlargement and chest computed tomography revealed an over-dilated oesophagus constricting the trachea. The patient was referred to chest surgery clinic with a suspected diagnosis of achalasia. Barium-oesophagogram and endoscopic evaluation of the oesophagus confirmed the diagnosis of achalasia. The patient underwent Heller myotomy and oesophagogastrostomy. He was recovered in one week after the surgery without any complaint of dyspnea. Spirometry tests and chest X-ray resulted normal in one year. With this case of achalasia who used asthma treatment unnecessarily,we wanted to emphasize the importance of differential diagnosis of difficult asthma.